Semaglutide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes and heart or blood vessel disease.
Promotes muscle regeneration and increases exercise endurance [1-10]
Helps lose weight  [11-16]
Lowers the risk of heart disease  [17-21]
Accelerates wound healing [22-23]
Boosts brain power [24-35]
Lowers blood pressure [36-38]
Improves blood sugar levels and treats symptoms of diabetes [39-46]
Treats lung injuries  [47-50]
Improves eye health [51-52]
GW0742 Peptide is a synthetic compound belonging to the class of peroxisome proliferator-activated receptor (PPAR) agonists. It has been extensively studied for its potential therapeutic effects in various conditions, including skeletal muscle insulin resistance, inhibits acute lung injury, diet-induced obesity, cardiac hypertrophy, and hypoxia-induced pulmonary hypertension.
GW0742 has gained attention in scientific research due to its potential therapeutic applications. It has been studied for its effects on fat metabolism, glucose homeostasis, and cardiovascular health. Some of the reported benefits of GW0742 include improved insulin sensitivity, enhanced fatty acid oxidation, and the potential to reduce inflammation and atherosclerosis.
Research on GW0742 is ongoing, and its potential applications are being explored in clinical trials in various fields, including metabolic disorders, cardiovascular diseases, and neurodegenerative diseases. However, it’s important to note that GW0742 is still primarily an investigational compound, and further studies are needed to fully understand its effectiveness, safety, and potential clinical applications.
GW0742 works by selectively activating peroxisome proliferator-activated receptor delta (PPARδ), a nuclear receptor that plays a crucial role in regulating gene expression and controlling various physiological processes. PPARδ is abundantly expressed in tissues involved in lipid synthesis, such as skeletal muscle, liver, and adipose tissue.
When GW0742 binds to and activates PPARδ, it initiates a cascade of cellular events that affect gene expression and metabolism. Here are some key mechanisms through which GW0742 exerts its effects:
Lipid Metabolism: GW0742 activation of PPARδ promotes the oxidation of fatty acids in various tissues, including skeletal muscle and liver. This leads to increased fatty acid uptake, enhanced mitochondrial biogenesis, and improved lipid synthesis. Consequently, GW0742 can potentially increase fat burning, enhance lipid metabolism, and decrease lipid accumulation.
Glucose Homeostasis: PPARδ activation by GW0742 has been shown to enhance insulin sensitivity and improve glucose utilization. It promotes glucose uptake in skeletal muscle and adipose tissue, thereby improving glucose homeostasis and potentially aiding in the management of conditions like type 2 diabetes.
Inflammation and Atherosclerosis: PPARδ activation by GW0742 has been found to possess anti-inflammatory properties. It can suppress the expression of inflammatory mediators and reduce the recruitment of immune cells to inflamed tissues. Additionally, GW0742 has shown potential in reducing atherosclerotic plaque formation and improving vascular health.
Energy Balance and Metabolic Flexibility: PPARδ activation by GW0742 has been associated with increased energy expenditure and improved metabolic flexibility. It can promote the utilization of both glucose and fatty acids as energy sources, enabling the body to adapt to different metabolic demands.
It’s important to note that while GW0742 shows promise in preclinical and experimental studies, further research is needed to fully understand its mechanisms of action and evaluate its potential therapeutic applications.
Are you looking to maximize your athletic performance, increase muscle regeneration, and push your exercise endurance to new heights? Look no further than GW0742, a powerful compound that has shown remarkable potential in promoting muscle regeneration and enhancing exercise endurance. Backed by scientific research, GW0742 is a game-changer for athletes and fitness enthusiasts seeking to unlock their full potential.
GW0742 has been found to play a vital role in promoting muscle regeneration. By activating peroxisome proliferator-activated receptor delta (PPARδ), GW0742 stimulates the growth and repair of muscle tissue. Research has shown that PPARδ activation leads to increased muscle fiber formation, accelerated muscle recovery, and reduced muscle damage following intense exercise. This means faster recovery times, allowing you to bounce back stronger after each workout.
One of the key mechanisms through which GW0742 promotes muscle regeneration is by enhancing mitochondrial biogenesis. Mitochondria are the powerhouses of our cells, responsible for generating energy. GW0742 stimulates the production of new mitochondria, increasing the energy capacity of muscle cells and enhancing their overall performance. This boost in mitochondrial function translates into improved endurance, allowing you to push through intense workouts with greater stamina.
GW0742 has been shown to significantly enhance exercise endurance, making it a valuable tool for athletes and individuals engaged in physical training. By activating PPARδ, GW0742 enhances the oxidation of fatty acids for energy, sparing glycogen reserves and delaying fatigue. This metabolic shift allows for prolonged exercise duration and improved performance, enabling you to go the extra mile and surpass your previous limits of physical endurance.
Enhanced Fat Utilization:
In addition to boosting endurance, GW0742 helps optimize fat utilization during exercise. By activating PPARδ, GW0742 increases the uptake and oxidation of fatty acids in muscle tissue, enabling your body to tap into its fat stores as a fuel source. This not only aids in weight management but also enhances exercise efficiency by preserving glycogen stores for high-intensity efforts.
Are you ready to embark on a transformative weight loss journey? Look no further than GW0742, a potent compound that has gained significant attention for its ability to aid in weight loss. Supported by scientific research, GW0742 is a game-changer for individuals seeking effective weight management. Get ready to unlock your body’s potential and achieve your weight loss goals with GW0742.
Fat Burning Powerhouse:
GW0742 has been shown to activate peroxisome proliferator-activated receptor delta (PPARδ), a key regulator of fat metabolism. Through its direct activation, GW0742 enhances the body’s ability to burn fat as a fuel source. Research has demonstrated that PPARδ activation promotes increased fatty acid oxidation, resulting in reduced fat accumulation and improved weight management. This means that GW0742 can help you shed those stubborn pounds by up fat metabolism and maximizing your body’s natural fat-burning capabilities.
Boosting Metabolic Rate:
By activating PPARδ, GW0742 also has the potential to increase metabolic rate. A higher metabolic rate means your body can burn more calories throughout the day, even during periods of rest. Research studies have shown that PPARδ activation with GW0742 leads to enhanced energy expenditure and increased metabolic efficiency. This metabolic boost can support weight loss efforts by creating a calorie deficit, aiding in achieving and maintaining a healthy body weight.
Controlling appetite is crucial for successful weight loss, and GW0742 has been found to play a role in appetite regulation. PPARδ activation with GW0742 has been associated with reduced food intake and increased satiety. By curbing cravings high sugar intake and promoting feelings of fullness, GW0742 can help you adhere to a calorie-restricted diet, making it easier to achieve sustainable weight loss.
Preservation of Lean Muscle Mass:
One of the challenges in weight and body fat loss is preserving lean muscle mass while shedding excess fat. GW0742 offers potential benefits in this area as well. Studies have shown that PPARδ activation helps maintain muscle mass during weight and body fat loss by promoting muscle fiber remodeling and preventing muscle wasting. Preserving lean muscle is essential for maintaining a healthy metabolism and achieving a toned and sculpted physique.
Heart disease is a significant health concern worldwide, and finding effective strategies to lower the risk is crucial. Introducing GW0742, a compound that has shown promising potential in reducing the risk of heart disease. Backed by scientific research, GW0742 offers a unique approach to cardiovascular health. Discover how GW0742 can become your ally in promoting a healthy heart and safeguarding against heart disease.
Chronic inflammation plays a central role in the development and progression of heart disease. GW0742 has been found to possess potent anti-inflammatory properties by activating peroxisome proliferator-activated receptor delta (PPARδ). By reducing inflammation within the cardiovascular system, GW0742 may help protect against conditions such as atherosclerosis and endothelial dysfunction, which contribute to heart disease.
Lipid Profile Improvement:
Maintaining healthy lipid levels is vital for cardiovascular health. GW0742 has been shown to improve lipid profiles by increasing high-density lipoprotein cholesterol (HDL-C), commonly known as “good” cholesterol, and reducing triglyceride levels. By enhancing metabolism of lipids and promoting the clearance of harmful lipids from the bloodstream, GW0742 supports a healthy lipid profile and reduces the risk of heart disease.
Enhanced Glucose Control:
Poor glucose control and insulin resistance are often associated with an increased risk of heart disease. GW0742 has demonstrated the ability to improve glucose tolerance and enhance insulin sensitivity, both of which are essential for maintaining optimal cardiovascular health. By promoting better glucose control, GW0742 may help mitigate the risk factors associated with heart disease.
Protection Against Oxidative Stress:
Oxidative stress is a key contributor to the development of heart disease. GW0742 possesses potent antioxidant properties, which can help counteract the damaging effects of oxidative stress reduce free radicals on the cardiovascular system. By neutralizing free radicals and reducing oxidative damage, GW0742 provides a protective shield for the heart and lowers the risk of cardiovascular complications.
Wound healing is a complex process that is essential for the body’s ability to repair damaged tissue. Introducing GW0742, a remarkable compound that has shown potential in accelerating wound healing. With its unique properties and scientific backing, GW0742 offers a promising approach to expedite the healing process and promote optimal recovery. Explore how GW0742 can be a powerful ally in achieving faster wound healing.
Stimulation of Angiogenesis:
Angiogenesis, the formation of new blood vessels, is a crucial step in wound healing as it delivers oxygen and nutrients to the healing site. GW0742 has been found to promote angiogenesis by activating peroxisome proliferator-activated receptor delta (PPARδ). By enhancing blood vessel formation, GW0742 facilitates efficient nutrient and oxygen supply to the wound area, promoting faster healing.
Modulation of Inflammation:
Inflammation is an essential component of the wound healing process; however, prolonged or excessive inflammation can impede proper healing. GW0742 possesses anti-inflammatory properties, which can help regulate the inflammatory response during wound healing. By modulating inflammation, GW0742 supports a balanced immune response, reducing excessive inflammation and promoting optimal healing conditions.
Promotion of Cell Proliferation and Migration:
GW0742 has been shown to stimulate cell proliferation and migration, which are critical aspects of wound healing. It promotes the proliferation of fibroblasts, the cells responsible for producing collagen, a key component of the wound matrix . Additionally, GW0742 enhances the migration of keratinocytes, the cells involved in re-epithelialization, the process of forming a new outer layer of skin over the wound . By enhancing these cellular processes, GW0742 accelerates wound closure and overall healing.
Collagen Synthesis and Remodeling:
Collagen is essential for wound healing as it provides structural support to the repairing tissue. GW0742 has been shown to stimulate collagen synthesis and remodeling, contributing to the strength and integrity of the healing wound. By promoting collagen production and organization, GW0742 enhances the quality of the healing tissue, leading to improved wound healing outcomes.
In the pursuit of optimal cognitive function and mental clarity, GW0742 emerges as a promising ally. This powerful compound has shown potential in boosting brain power and enhancing cognitive performance. With its unique mechanisms and supported by scientific research, GW0742 offers a path to unlock your brain’s true potential. Discover how GW0742 can be a game-changer in maximizing cognitive abilities.
Activation of PPARδ:
GW0742 acts as an agonist for peroxisome proliferator-activated receptor delta (PPARδ), a key protein involved in various cellular processes, including cognition. Activation of PPARδ by GW0742 has been shown to improve cognitive function and memory in animal models. By stimulating PPARδ, GW0742 enhances neuroplasticity and neurogenesis, leading to improved learning, memory formation, and overall brain performance.
GW0742 exhibits neuroprotective properties, shielding the brain from damage caused by oxidative stress and inflammation. It activates cellular pathways that promote neuronal survival, reducing the risk of cognitive decline. This neuroprotective effect of GW0742 can help maintain brain health and preserve cognitive abilities over time.
Enhanced Energy Metabolism:
Optimal brain function requires adequate energy supply. GW0742 has been shown to enhance energy metabolism by promoting mitochondrial biogenesis. Mitochondria are the powerhouses of cells, including brain cells, responsible for generating energy. By boosting mitochondrial function, GW0742 provides the brain with a greater energy reserve, supporting mental alertness, focus, and overall cognitive performance.
Improved Mood and Mental Well-being:
Cognitive performance is closely linked to mood and mental well-being. GW0742 has been found to exert antidepressant-like effects by regulating neurotransmitter systems involved in mood regulation, such as serotonin and dopamine. By promoting a positive mood and reducing depressive symptoms, GW0742 enhances cognitive abilities, including attention, motivation, and decision-making.
High blood pressure, or hypertension, is a significant risk factor for various cardiovascular diseases. Addressing this health concern requires effective strategies to lower blood pressure and maintain optimal cardiovascular health. GW0742, a potent compound with unique properties, has shown promise in helping to lower high blood pressure. Let’s explore how GW0742 can be a valuable ally in your journey towards better cardiovascular well-being.
Activation of PPARδ:
GW0742 acts as an agonist for peroxisome proliferator-activated receptor delta (PPARδ), a key regulator of metabolic processes, including blood pressure regulation. Activation of PPARδ by GW0742 has been found to promote vasodilation, a process in which blood vessels relax and widen, leading to a reduction in blood pressure. By enhancing PPARδ activity, GW0742 helps restore vascular health and contributes to maintaining optimal blood pressure levels.
Inflammation plays a significant role in the development and progression of hypertension. GW0742 has demonstrated anti-inflammatory properties by suppressing the release of pro-inflammatory molecules . By reducing inflammation, GW0742 helps to alleviate stress on blood vessels and promotes a healthier vascular environment, contributing to improved blood pressure control.
Improvement of Endothelial Function:
The endothelium, the inner lining of blood vessels, plays a crucial role in regulating blood pressure. Impaired endothelial function is associated with hypertension. GW0742 has been shown to enhance endothelial function by increasing the production of nitric oxide (NO), a potent vasodilator. By promoting NO synthesis, GW0742 supports proper blood vessel relaxation and improves blood flow in pulmonary vessels, ultimately leading to lower blood pressure.
Beyond its blood pressure-lowering effects, GW0742 offers additional cardiovascular benefits. It has been found to reduce oxidative stress, which contributes to blood vessel damage. Additionally, GW0742 exhibits cardioprotective properties by enhancing energy metabolism in the heart muscle and reducing cardiac hypertrophy. These effects contribute to overall cardiovascular health and lower the risk of heart disease.
Diabetes is a chronic condition characterized by high blood sugar levels that can lead to various complications. Effective management of diabetes involves maintaining stable blood sugar levels and alleviating symptoms associated with the disease. GW0742, a remarkable compound with unique properties, has shown promise in improving blood sugar control and treating symptoms of diabetes. Let’s explore how GW0742 can be a valuable tool in your journey toward better diabetes management.
Activation of PPARδ:
GW0742 acts as an agonist for peroxisome proliferator-activated receptor delta (PPARδ), a key regulator of glucose and lipid hydrolysis. Activation of PPARδ by GW0742 has been found to improve insulin sensitivity, allowing cells to effectively utilize glucose. By enhancing PPARδ activity, GW0742 helps to regulate blood sugar levels and mitigate insulin resistance, a hallmark of type 2 diabetes.
Enhanced Glucose Uptake and Utilization:
GW0742 has been shown to promote glucose uptake in mouse skeletal muscle and cells, facilitating glucose transport and its utilization for energy production. This effect helps to lower blood sugar levels by increasing the clearance of glucose from the bloodstream. By improving glucose uptake and utilization, GW0742 supports better glycemic control, aiding in the management of diabetes.
Protection of Pancreatic Beta Cells:
Pancreatic beta cells play a vital role in insulin production. In diabetes, these cells may become damaged, leading to decreased insulin secretion. GW0742 has demonstrated protective effects on pancreatic beta cells, preserving their function and promoting insulin production. By preserving the integrity of beta cells, GW0742 helps to maintain adequate insulin levels and improve blood sugar control in individuals with diabetes.
Anti-Inflammatory and Antioxidant Properties:
Inflammation and oxidative stress are closely linked to the development and progression of diabetes. GW0742 exhibits anti-inflammatory properties by suppressing the release of pro-inflammatory molecules . Additionally, it exerts antioxidant effects by reducing oxidative stress and neutralizing harmful free radicals . By reducing inflammation and oxidative damage, GW0742 helps to alleviate stress on pancreatic cells and improve their function, contributing to better blood sugar management.
Lung injuries, such as acute respiratory distress syndrome (ARDS) and pulmonary fibrosis, can have severe consequences for respiratory function and overall heart health. The search for effective treatments to combat these conditions has led researchers to explore the therapeutic potential of GW0742. This remarkable compound has demonstrated promising effects in treating lung injuries, offering hope for patients and healthcare professionals alike. Let’s delve into the ways GW0742 can be a valuable tool in the treatment of lung injuries.
Inflammatory processes play a critical role in the development and progression of lung injuries. GW0742 has shown potent anti-inflammatory properties by inhibiting the release of pro-inflammatory molecules and reducing the infiltration of immune cells into the lungs. By attenuating inflammation, GW0742 helps to mitigate tissue damage and promote the healing process in lung injuries.
Modulation of Fibrosis:
Pulmonary fibrosis, characterized by excessive scarring and thickening of lung tissue, is a common consequence of various lung injuries. GW0742 has been found to inhibit the activation of fibroblasts, the cells responsible for collagen production and tissue remodeling. This modulation of fibrosis pathways can help to prevent or reduce the progression of pulmonary fibrosis, ultimately improving lung function and patient outcomes.
Oxidative stress, caused by an imbalance between harmful free radicals and the body’s antioxidant defenses, contributes to lung injury and worsens its outcomes. GW0742 has been shown to possess potent antioxidant properties, effectively neutralizing free radicals and reducing oxidative damage in the lungs . By protecting lung cells from oxidative stress, GW0742 aids in preserving their integrity and promoting tissue repair.
The alveoli, tiny air sacs in the lungs, are responsible for gas exchange. In lung injuries, the alveolar structure may be compromised, leading to impaired respiratory function. GW0742 has demonstrated the ability to promote alveolar regeneration by stimulating the proliferation and differentiation of alveolar epithelial cells. This regenerative effect helps to restore the normal structure and function of the lungs, leading to improved respiratory capacity.
Maintaining healthy vision is crucial for overall well-being and quality of life. Researchers have been exploring various compounds for their potential benefits in promoting eye health. Among these compounds, GW0742 has emerged as a promising candidate. Its unique properties have shown the potential to improve eye health and support visual function. Let’s delve into the ways GW0742 can contribute to maintaining and enhancing healthy eyes.
Oxidative stress is a major contributor to age-related eye diseases such as age-related macular degeneration (AMD) and cataracts. GW0742 exhibits potent antioxidant properties, which help neutralize harmful free radicals and reduce oxidative damage in the eye tissues. By reducing oxidative stress, GW0742 may help protect against age-related vision decline and maintain optimal eye health.
Chronic inflammation is implicated in various eye conditions, including uveitis and diabetic retinopathy. GW0742 has been shown to possess anti-inflammatory properties by inhibiting the release of pro-inflammatory molecules and modulating inflammatory pathways. By reducing inflammation in the eye, GW0742 may help alleviate symptoms and mitigate the progression of inflammatory eye disorders.
The retina plays a crucial role in vision, and maintaining the health and survival of retinal cells is essential. GW0742 has been found to enhance the survival of retinal cells by activating cellular pathways that promote cell growth, survival, and regeneration. By supporting retinal cell health, GW0742 may contribute to maintaining optimal visual function and preventing degenerative conditions.
Neurodegenerative diseases, such as glaucoma, can lead to the progressive loss of vision. GW0742 has shown neuroprotective effects by reducing neuronal damage and preserving nerve cell function . By protecting the optic nerve and retinal ganglion cells, GW0742 may help delay the onset or slow the progression of neurodegenerative eye diseases, ultimately preserving visual function.
Finding the appropriate GW0742 dosage is crucial for achieving optimal results while minimizing potential side effects. The recommended dosage can vary depending on individual factors and goals. It is essential to consult with a healthcare professional or follow the instructions provided by the manufacturer for personalized guidance.
The recommended GW0742 dosage can vary depending on individual factors. It is crucial to consult with a healthcare professional for personalized dosage recommendations and follow the instructions provided by the manufacturer.
While GW0742 has shown potential benefits in various aspects of health, it’s important to note that like any compound, it may also have potential side effects. However, it’s crucial to keep in mind that the information available on GW0742’s specific side effects may be limited due to its status as a research chemical.
Liver Toxicity: Some studies have suggested that certain compounds in the same class as GW0742 may have hepatotoxic effects, meaning they could potentially harm the liver. However, it’s important to note that specific information on GW0742’s liver toxicity profile may be limited.
Hormonal Imbalance: GW0742 belongs to a class of compounds known as PPAR delta agonists, which can affect various metabolic processes and hormone regulation. PPAR delta agonists have been associated with potential effects on hormonal balance, including changes in metabolism of lipids and glucose homeostasis. It’s crucial to consult with a healthcare professional before using GW0742 or any PPAR agonist.
Off-Target Effects: While GW0742 primarily targets PPAR receptors, it’s possible that it may interact with other receptors or cellular pathways, leading to unforeseen side effects. Further research is needed to fully understand the potential off-target effects of GW0742.
Limited Human Studies: As GW0742 is primarily used in preclinical studies and research, there is limited information on its specific side effects in humans. Most available information comes from studies on similar compounds within the same class.
Drug Interactions: GW0742 may interact with other medications or supplements, leading to potential complications or adverse reactions. It’s essential to inform your healthcare provider about any medications or supplements you are taking before considering GW0742.
It’s crucial to note that the information provided here is based on general knowledge of compounds within the same class as GW0742 and not specific to GW0742 itself. As GW0742 is primarily used in research settings, it is important to consult with a healthcare professional or a qualified researcher for the most up-to-date and accurate information regarding its side effects.
GW0742, a selective peroxisome proliferator-activated receptor (PPAR) delta agonist, has also been studied for its potential role in cancer research. PPAR delta is a nuclear receptor involved in regulating various cellular processes, including cell proliferation, differentiation, and apoptosis.
Here are a few key aspects of GW0742’s role in cancer research:
Anti-proliferative effects: GW0742 has shown promising anti-proliferative effects in various cancer cell lines. Studies have demonstrated its ability to inhibit cell growth and induce apoptosis, thereby reducing the proliferation of cancer cells.
Inhibition of angiogenesis: Angiogenesis, the formation of new blood vessels, plays a crucial role in tumor growth and metastasis. GW0742 has been found to inhibit angiogenesis by suppressing the production of pro-angiogenic factors, thereby reducing the blood supply to tumors and hindering their progression.
Modulation of inflammatory response: Chronic inflammation is associated with an increased risk of cancer development and progression. GW0742 has demonstrated anti-inflammatory properties by suppressing the production of pro-inflammatory cytokines and chemokines, which can help create an unfavorable environment for tumor growth.
GW0742 has been found to promote fat oxidation and increase the utilization of fatty acids as an energy source. By activating PPARδ, it can stimulate the expression of genes involved in fat burning and enhance endurance in certain studies. However, it is essential to note that research on GW0742 is still in the early stages, and its safety and efficacy for fat burning in humans are not fully established.
The safety of GW0742 has not been extensively studied in humans, and its long-term effects remain uncertain. As with any research chemical or experimental compound, it is crucial to exercise caution and consult with a qualified healthcare professional before using GW0742. Additionally, it is essential to adhere to recommended dosages and avoid combining it with other substances unless under the supervision of a healthcare provider.
GW0742’s primary use is in scientific research, particularly in studies related to PPARδ activation and its potential effects on metabolism, energy regulation, and other physiological processes. It is not approved for medical use or consumption by regulatory authorities.
The potential benefits of GW0742 are still being investigated, and current research primarily focuses on its effects on metabolism, lipid regulation, and endurance. It may have implications for understanding fat metabolism and could have potential applications in sports performance and metabolic disorders research. However, until further research is conducted and its safety and efficacy are better understood, no specific benefits can be conclusively stated.
Cardarine, also known as GW501516, is a different compound often confused with GW0742. Cardarine is another PPAR delta agonist and has been studied for its potential fat-burning properties. However, it is essential to reiterate that research on both GW0742 and GW501516 is ongoing, and any claims about specific weight loss amounts are premature and speculative.
Yes, GW0742 Peptide has been found to mitigate cardiac hypertrophy caused by rapid cardiac growth. By activating PPAR pathways, it can inhibit pathological cardiac remodeling and reduce hypertrophic responses in the heart.
Proper dosages of GW0742 Peptide may vary depending on the specific condition being treated, the model organism used (if in animal studies), and the formulation of the peptide. It is essential to consult with qualified researchers, medical professionals, or experts in the field to determine safe and effective dosing protocols.
Narkar VA, et al. (2008). AMPK and PPAR delta agonists are exercise mimetics. Cell, 134(3), 405-415.
Hwang JT, et al. (2009). Activation of PPARδ by agonist GW501516 attenuates fatty acid-induced endothelial cell apoptosis by inducing the expression of uncoupling protein 3. FEBS Letters, 583(21), 3589-3594.
Tanaka T, et al. (2003). Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proceedings of the National Academy of Sciences, 100(26), 15924-15929.
Wang YX, et al. (2004). Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biology, 2(10), e294.
Oliver WR Jr, et al. (2001). A selective PPAR delta agonist promotes reverse cholesterol transport. Proceedings of the National Academy of Sciences, 98(9), 5306-5311.
Burant CF, et al. (2005). Troglitazone action is independent of adipose tissue. Journal of Clinical Investigation, 115(4), 921-928.
Wang YX, et al. (2003). Activation of PPARδ increases mitochondrial function and fatty acid oxidation in skeletal muscle. Proceedings of the National Academy of Sciences, 101(20), 6570-6575.
Yan B, et al. (2016). Activation of PPARδ attenuates cardiac fibrosis and endothelial dysfunction in hypertensive rats. Frontiers in Pharmacology, 7, 485.
Lalloyer F, et al. (2009). Peroxisome proliferator-activated receptor δ agonists: an innovative approach to combat metabolic syndrome. Pharmaceutical Research, 26(12), 2697-2708.
Goikoetxea MJ, et al. (2017). Effect of a PPARδ agonist on brain and peripheral markers of inflammation in a rat model of Alzheimer’s disease. European Journal of Neuroscience, 46(9), 2446-2457.
Cheng L, et al. (2019). PPARδ agonist GW0742 ameliorates LPS-induced inflammation in synovial fibroblasts via suppressing NF-κB signaling pathway. Cell Biochemistry and Function, 37(8), 590-598.
Park SH, et al. (2016). Activation of PPARδ promotes wound healing by increasing angiogenesis and up-regulating VEGF in MRL mice. The FASEB Journal, 30(3), 800-809.
He W, et al. (2019). The PPARδ agonist GW0742 accelerates intestinal wound healing via YAP signaling and mitochondrial biogenesis. Life Sciences, 239, 116955.
Kimura K, et al. (2018). Activation of Peroxisome Proliferator-Activated Receptor-δ Stimulates Cell Proliferation and the Function of Proximal Tubular Cells. Journal of Biological Chemistry, 293(26), 10022-10034.
Karabulut AB, et al. (2021). PPARδ Agonist GW0742 Accelerates Epidermal Wound Healing by Promoting Ker.